TSE:ZYUS Stock Latest News
Company AnnouncementsZYUS Raises C$50,000 in Second Private-Placement Tranche5d ago
Company AnnouncementsZYUS Life Sciences Closes Insider-Funded First Tranche of Private Placement3w ago
Company AnnouncementsZYUS Posts Positive Phase 2a Data for Non-Opioid Cancer Pain Drug Trichomylin1M ago
Company AnnouncementsZYUS to Unveil Phase 2a Cancer Pain Trial Results as Governance Team Evolves1M ago- Company AnnouncementsZYUS Life Sciences Secures CAD$1.9 Million Loan Financing With Insider Participation2M ago
Company AnnouncementsZYUS Life Sciences closes ninth tranche of secured loan financing to bolster working capital2M agoCompany AnnouncementsZYUS Reaches Key Milestone in Phase 2a Trial of Non-Opioid Cancer Pain Drug7M ago
Company AnnouncementsZYUS Reaches Key Milestone in Phase 2a Trial of Non-Opioid Cancer Pain Drug7M ago
- Company AnnouncementsZYUS Life Sciences Closes Unit Offering and Draws on Credit Line7M ago
- Company AnnouncementsZYUS Life Sciences Closes First Tranche of Downsized Private Placement7M ago
- Company AnnouncementsZYUS Cancels LIFE Offering, Shifts to New Financing and Expands Credit Line8M ago
- Company AnnouncementsZYUS Life Sciences Restarts LIFE Financing with Amended Offering Document9M ago
Company AnnouncementsZYUS Extends Subleases to 2030 and Converts Payables Into $4.4 Million Promissory Note9M ago
Company AnnouncementsZYUS Life Sciences Launches Up to C$16 Million LIFE Financing to Advance Non-Opioid Pain Drug10M ago
Company AnnouncementsZYUS Posts Encouraging Early Phase 2a Data for Non-Opioid Cancer Pain Drug10M ago
Company AnnouncementsZYUS Life Sciences Achieves Key Milestone in Cancer Pain Management Trial11M ago
Company AnnouncementsZYUS Life Sciences Closes First Tranche of Unit Offering and Issues Warrants1y ago
Company AnnouncementsZyus Life Sciences Advances Cancer Pain Treatment with Trichomylin® Study1y agoZYUS
Company AnnouncementsZYUS Life Sciences Secures Additional Funding to Advance Drug Development1y ago
Company AnnouncementsZYUS Life Sciences CEO Increases Stake Through Strategic Warrant Issuance1y ago